Pessary Market Expands Steadily from 2026 to 2033 | Persistence Market Resaerch

The global pessary market is on the rise, with a projected growth rate that reflects the increasing need for non-surgical treatments for pelvic floor disorders, particularly pelvic organ prolapse (POP) and urinary incontinence. This market is steadily expanding as more women seek conservative care options to address these conditions without resorting to surgery. As a critical part of women's healthcare, the pessary market is anticipated to grow at a compound annual growth rate (CAGR) of 5.5% between 2026 and 2033, with the market value expected to reach $838.4 million by 2033. This article delves into the market's current trends, growth drivers, regional variations, and key industry players, offering an in-depth look at the forces shaping this dynamic sector.

Download Your Free Sample & Explore Key Insights: https://www.persistencemarketresearch.com/samples/33288

Overview of the Pessary Market

Pessaries are medical devices designed for the management of pelvic floor disorders, such as pelvic organ prolapse and urinary incontinence, which predominantly affect women, especially those over the age of 50. These devices are non-invasive, cost-effective, and reversible, making them an attractive option for women who prefer to avoid surgery. The increasing prevalence of pelvic floor disorders, coupled with rising awareness about non-surgical alternatives, is driving the global demand for pessaries.

The global pessary market is growing due to a variety of factors, including the aging population, increased awareness of pelvic health, and the rising number of women seeking alternatives to surgery. In particular, the growing focus on outpatient care, preventive strategies, and minimally invasive treatment options is expected to propel the market further. Additionally, innovations in pessary design, materials, and fitting systems have led to improved patient comfort and compliance, which in turn drives market growth.

Market Statistics and Growth Drivers

The pessary market is projected to grow from $510.4 million in 2026 to $838.4 million by 2033, reflecting a strong CAGR of 5.5% during this period. This growth is fueled by several key factors, such as the rising prevalence of pelvic floor disorders, an increase in the number of women diagnosed with urinary incontinence, and the aging female population. The ongoing shift toward conservative, non-surgical treatments for these conditions further accelerates market expansion.

The primary drivers of the market include advancements in pessary technology, such as the development of medical-grade silicone, which improves flexibility, biocompatibility, and patient comfort. Moreover, an increasing number of healthcare facilities and gynecological practitioners are becoming more familiar with pessary fitting, making it easier for patients to access these non-invasive treatment options. A further push is coming from the growing emphasis on preventive care and outpatient management, which aligns well with the use of pessaries in managing chronic pelvic floor disorders.

Key Growth Segments

Leading Segment: The ring pessary segment is expected to dominate the market, owing to its versatility, ease of use, and high patient comfort. This segment leads due to its applicability in treating mild to moderate cases of pelvic organ prolapse and urinary incontinence. Ring pessaries are also favored by clinicians for their straightforward fitting process and long-term usability.

Leading Geographical Region: North America is anticipated to maintain its dominant share of the market, accounting for 47.3% in 2026. This is largely due to the highly developed healthcare infrastructure in the United States and Canada, the widespread awareness of pelvic floor disorders, and the strong adoption of conservative treatments like pessaries.

Key Highlights from the Report

• The global pessary market size is expected to reach $838.4 million by 2033, growing at a CAGR of 5.5% from 2026 to 2033.
• North America holds the largest share of the market, accounting for 47.3% in 2026.
• The Asia Pacific region is expected to grow the fastest, with a CAGR of 7.5% from 2026 to 2033.
• Ring pessaries dominate the product segment, with a 46.5% revenue share in 2026.
• The pelvic organ prolapse indication is the leading clinical application, accounting for 62% of the market in 2026.
• Hospitals are the largest end-user segment, with a projected market share of 52.0% in 2026.

Market Segmentation

The pessary market can be segmented in several ways, including by product type, clinical application, end-user, and region. Each of these segments plays a pivotal role in the market's overall dynamics.

Product Type

The product type segmentation reveals that ring pessaries lead the market in terms of both revenue and usage. Ring pessaries are widely used for managing pelvic organ prolapse and urinary incontinence due to their ease of insertion, long-term comfort, and minimal complications. These devices are designed to be flexible, allowing them to conform to the shape of the vaginal walls, thereby improving retention and reducing discomfort.

Other types of pessaries, such as incontinence rings, are also gaining traction, particularly for managing urinary incontinence. These devices are designed to provide targeted support for the bladder, reducing symptoms of stress urinary incontinence. As demand for non-surgical treatments increases, the incontinence ring segment is expected to witness significant growth over the coming years.

Clinical Application

In terms of clinical applications, pelvic organ prolapse (POP) remains the largest segment of the pessary market. POP, a condition in which pelvic organs (such as the bladder, uterus, or rectum) descend from their normal positions due to weakened pelvic muscles, is most common in postmenopausal women and those who have had multiple childbirths. Pessaries are a popular first-line treatment for this condition, particularly for women who wish to avoid surgery.
Urinary incontinence is another significant application area, driven by the increasing number of women diagnosed with this condition. With growing awareness and early diagnosis, urinary incontinence treatment options like pessaries are gaining acceptance as effective non-invasive solutions.

End-User

The hospital segment is expected to maintain its dominance in the pessary market, driven by high patient volumes and the presence of specialized medical staff capable of fitting pessaries. Hospitals typically handle the majority of moderate to severe cases of pelvic floor disorders, especially those requiring thorough evaluation and long-term management.

On the other hand, outpatient clinics and specialty women's health clinics are also expected to witness significant growth. These facilities offer more accessible and cost-effective options for women seeking conservative treatments. Additionally, the expansion of community-based health services and telemedicine is expected to enhance the availability of pessaries, especially in rural and underserved areas.

Get Custom Insights Designed for Your Business: https://www.persistencemarketresearch.com/request-customization/33288

Regional Insights

North America

North America leads the global pessary market, accounting for the largest share of the market value. The United States, in particular, benefits from a well-established healthcare infrastructure, including advanced gynecological services and widespread awareness of pelvic health. The region's high diagnosis rates of pelvic organ prolapse and urinary incontinence, coupled with favorable reimbursement policies for non-surgical treatments, support the broad adoption of pessaries. North America's emphasis on preventive care and outpatient management further contributes to the market's growth.

Europe

Europe's pessary market is characterized by steady growth, driven by an aging female population and high healthcare access. Countries such as Germany, the United Kingdom, France, and Italy have well-established healthcare systems and emphasize non-surgical treatments. Increasing patient awareness, the availability of standardized pessary products, and improving access to urogynecological services in the region contribute to the steady market expansion.

Asia Pacific

The Asia Pacific region is expected to experience the fastest growth in the pessary market, primarily due to improving healthcare infrastructure, increasing awareness of pelvic health, and rising prevalence of pelvic organ prolapse. Countries such as China, India, and Japan are seeing a significant rise in the demand for non-surgical pelvic floor disorder treatments. Additionally, rising healthcare investments, government initiatives to modernize healthcare systems, and growing numbers of private women's health clinics are facilitating market growth in the region.

Market Drivers

Several factors are driving the global pessary market. The most prominent of these is the rising prevalence of pelvic floor disorders, including pelvic organ prolapse and urinary incontinence, which are becoming more common as populations age. As these conditions become more prevalent, the demand for conservative, non-surgical treatments like pessaries continues to rise.
Moreover, innovations in pessary design, such as the use of medical-grade silicone and anatomically tailored fittings, have made these devices more comfortable and user-friendly. As a result, physicians and patients alike are increasingly opting for pessaries as an effective, long-term management solution.

Market Restraints

Despite their growing popularity, the pessary market faces several challenges. One of the main obstacles is patient compliance. Long-term use of pessaries requires regular maintenance, including cleaning, refitting, and follow-up appointments. For some patients, these requirements can be inconvenient or burdensome, leading to poor adherence to prescribed regimens.

In addition, cultural sensitivities and limited awareness in emerging markets present barriers to broader adoption. In many low-income countries, pelvic floor disorders are underdiagnosed, and patients may be unaware of non-surgical treatment options. Furthermore, inconsistent reimbursement policies and a lack of access to trained gynecologists hinder the widespread use of pessaries in these regions.

Market Opportunities

The growing shift towards conservative care and preventive women's health presents a significant opportunity for the pessary market. As healthcare systems worldwide prioritize non-invasive, low-cost treatments, pessaries align perfectly with this trend. Increasing awareness, better access to gynecological services, and expanding outpatient care networks are expected to drive future growth in the market.

In addition, manufacturers are exploring new opportunities by developing customizable pessaries, disposable devices, and improved sizing systems. These innovations aim to enhance ease of use, increase patient independence, and improve comfort, thereby increasing patient compliance and adoption rates. Furthermore, the integration of pessary management into holistic pelvic floor therapy programs, which may include physical therapy, lifestyle interventions, and preventive measures, provides additional opportunities to improve treatment outcomes and patient satisfaction.

Checkout Now & Download Complete Market Report: https://www.persistencemarketresearch.com/checkout/33288

Company Insights

The global pessary market is highly competitive, with several key players driving innovation and market growth. These companies are focusing on product development, strategic partnerships, and expanding their distribution networks to strengthen their market positions. Below is a list of some of the leading companies in the pessary market:

• CooperSurgical Inc.
• Bliss GVS Pharma
• MedGyn
• Panpac Medical Corporation
• Bioteque America
• Personal Medical Corporation
• Dr. Arabin GmbH & Co.
• Kangge Medical
• Integra Lifesciences
• Wallach Surgical Devices
• Medesign
• Coloplast
• Cosm Medical

Market Segmentation

By Product

Ring Pessaries
Lever Pessaries
Incontinence Rings
Marland
Others

By Technology

Pelvic Organ Prolapse
Urinary Incontinences

By End User

Hospitals
Specialty Clinics
Ambulatory Surgery Centers

By Region

North America
Europe
East Asia
South Asia and Oceania
Latin America
Middle East and Africa

Recent Developments

Mediplus (May 2025) announced the expansion of its POPYTM pelvic organ prolapse pessary product portfolio, introducing five additional sizes. This move is designed to improve anatomical fit and provide more options for treating women affected by pelvic organ prolapse, addressing the diverse needs of patients and enhancing treatment outcomes.

ConTIPI Medical (September 2024) entered a partnership with EVERSANA to support the commercial launch of its ProVate vaginal ring pessary in the U.S. market. The ProVate pessary is designed specifically for patients with pelvic organ prolapse, offering an innovative, non-surgical treatment option with enhanced patient comfort and usability.

Conclusion

The pessary market is poised for steady growth over the coming years, driven by increasing awareness of pelvic health, the rising prevalence of pelvic floor disorders, and a growing preference for non-surgical, conservative treatment options. The demand for pessaries is expected to continue expanding, particularly in regions such as North America and Asia Pacific, where healthcare infrastructure is improving and patient education is increasing. With innovations in product design, patient comfort, and clinical adoption, pessaries are becoming a cornerstone treatment in the management of pelvic organ prolapse and urinary incontinence.

Read More Related Reports:

Home Care Services Market https://www.persistencemarketresearch.com/market-research/home-care-services-market.asp
Bone and Joint Health Supplements Market https://www.persistencemarketresearch.com/market-research/bone-and-joint-health-supplements-market.asp
Adult Hemoglobinopathy Testing Market https://www.persistencemarketresearch.com/market-research/adult-hemoglobinopathy-testing-market.asp
Postoperative Pain Management Market https://www.persistencemarketresearch.com/market-research/postoperative-pain-management-market.asp

Contact Us:

Persistence Market Research
Second Floor, 150 Fleet Street, London, EC4A 2DQ, United Kingdom
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.